Funding
$211.0M
Models
1
Overview
Italian-founded surgical robotics company developing the Symani Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
CEO
Founded
HQ
Product
FDA status
CE mark
Clinical cases
Funding
Financial stage
Manufacturing
Key investors
REMIND study
Models (1)
View all models →MMI (Medical Microinstruments) on the deployment map
Where MMI (Medical Microinstruments)'s robots are verified operating. Explore the deployment map by place and type.
Relationships
Current leadership (1)
- Mark Toland CEOSEC-verified
Safety record
No incidents on record for MMI (Medical Microinstruments).
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
MMI (Medical Microinstruments) in third-party press
Funding rounds (4)
- Series C2024-02-21
$110M
Investors: Fidelity Management & Research Company (lead), Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital, Sambatech, Wellington Partners
- Series B2022-07-20
$75M
Investors: Deerfield Management (lead), RA Capital Management, Biostar Capital, Andera Partners, Fountain Healthcare Partners, Panakès Partners, Sambatech
- Series A2018-01-01
$24M
Investors: Andera Partners, Fountain Healthcare Partners, Panakès Partners, Wellington Partners
- Seed2016-01-01
$2M
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 18, 2026
Added to the verified registry
Common questions
- What is MMI (Medical Microinstruments)?
- Italian-founded surgical robotics company developing the Symani Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.
- What does MMI (Medical Microinstruments) make?
- MMI (Medical Microinstruments) has 1 robot model on the DEPLOY registry: Symani Surgical System (MMI (Medical Microinstruments) builds physical robots).
- Who is the CEO of MMI (Medical Microinstruments)?
- Mark Toland is the ceo of MMI (Medical Microinstruments), per the DEPLOY registry.
- Where is MMI (Medical Microinstruments) headquartered?
- MMI (Medical Microinstruments) is headquartered in Jacksonville, Florida, USA.
- How much funding has MMI (Medical Microinstruments) raised?
- MMI (Medical Microinstruments) has raised approximately $211M in disclosed funding on record in the DEPLOY registry.
- Where does MMI (Medical Microinstruments) operate robots?
- MMI (Medical Microinstruments) is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is MMI (Medical Microinstruments) a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, MMI (Medical Microinstruments) ranks in roughly the top 49% of companies tracked by the registry.
- Is MMI (Medical Microinstruments) safe?
- MMI (Medical Microinstruments) has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Claimed (not independently verified) · no sources on file · last reviewed 2026-07-18
Verification posture
Claimed (not independently verified)
Low confidence
Review state
Stable
Last reviewed 2026-07-18
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for MMI (Medical Microinstruments).In the press
Recent coverage mentioning MMI (Medical Microinstruments) from third-party publications. Automatically surfaced; not part of the verified registry record.
'Putting the body back together' with MMI's microsurgery robot
MedTech Dive profile of MMI's Symani Surgical System and Synaptix digital platform, which can be moved between operating rooms for microsurgical procedures including breast cancer…
MMI Receives FDA Authorization to Commercialize Symani Surgical System in the U.S.
Medical Microinstruments received FDA De Novo authorization to commercialize its Symani Surgical System in the U.S., building on proven clinical success in Europe.
MMI Raises $110 Million in Series C Financing
MMI raised $110M in Series C led by Fidelity Management & Research Company, the largest ever investment in microsurgery innovation. Funds support commercialization of Symani…
Medical Microinstruments collects $110M to fund surgical robot rollout
Medical Microinstruments secured $110M in venture capital funding to support the commercial rollout of its Symani robotic microsurgery system globally.
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
MMI raised $75M in Series B financing led by Deerfield Management with RA Capital and Biostar Capital. Company announced corporate redomicile from Italy to the United States.
Machine-readable surfaces
- Markdown mirror: /companies/mmi-symani.md
- RSS feed: /companies/mmi-symani/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/a0bb956c-fcf2-4374-b893-42388bad22be
- Revision history: /companies/mmi-symani/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Reality vs attention
MMI (Medical Microinstruments) draws attention at the 18th percentile but verifies reality at the insufficient-data level among surgical robots.
Analysis
Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 19, 2026